Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
BRANDYWINE REALTY TRUST (BDN)
|
Add to portfolio |
|
|
|
| Price: |
$14.02
| | Metrics |
| OS: |
172.1
|
M
| |
|
|
| Market cap: |
$2.41
|
B
| |
|
|
|
Net debt:
|
$527
|
M
| |
|
|
|
EV:
|
$2.94
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 486.8 | 534.9 | 580.4 | 544.3 | 520.5 | 525.5 | 602.6 | 597.0 |
| Revenue growth | -9.0% | -7.9% | 6.6% | 4.6% | -0.9% | -12.8% | 0.9% | 6.2% |
| Cost of goods sold | 363.8 | 400.7 | 442.4 | 424.3 | 251.3 | 255.7 | 469.9 | 465.1 |
| Gross profit | 123.0 | 134.2 | 138.0 | 120.1 | 269.2 | 269.8 | 132.8 | 131.8 |
| Gross margin | 25.3% | 25.1% | 23.8% | 22.1% | 51.7% | 51.3% | 22.0% | 22.1% |
| General and administrative | 30.2 | 30.3 | 32.2 | 27.8 | 28.5 | 26.6 | 29.4 | 26.8 |
| EBIT | 66.7 | 671.4 | 105.2 | 116.1 | 162.2 | 331.4 | 115.3 | 124.9 |
| EBIT margin | 13.7% | 125.5% | 18.1% | 21.3% | 31.2% | 63.1% | 19.1% | 20.9% |
| Pre-tax income | 12.4 | 307.1 | 34.5 | 135.9 | 120.5 | 40.5 | -30.7 | 6.0 |
| Income taxes | 0.0 | -0.2 | 0.0 | 0.4 | -0.6 | 0.0 | 0.0 | -1.0 |
| Tax rate | 0.4% | | 0.0% | 0.3% | | 0.0% | 0.0% | |
| Earnings from continuing ops | 11.9 | 305.1 | 33.9 | 134.1 | 114.6 | 33.0 | -37.6 | -1.2 |
| Earnings from discontinued ops | | | | | | | | 0.9 |
| Net income | 11.9 | 305.1 | 33.9 | 134.1 | 114.6 | 33.0 | -37.6 | -0.3 |
| Net margin | 2.4% | 57.0% | 5.8% | 24.6% | 22.0% | 6.3% | -6.2% | 0.0% |
| |
| Diluted EPS | $0.07 | $1.77 | $0.19 | $0.75 | $0.65 | $0.19 | ($0.21) | ($0.01) |
| Shares outstanding (diluted) | 172.3 | 172.3 | 176.7 | 179.6 | 176.8 | 176.0 | 178.2 | 166.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|